Proficio Capital Partners LLC Buys Shares of 2,294 Cigna Group $CI

Proficio Capital Partners LLC purchased a new position in Cigna Group (NYSE:CIFree Report) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 2,294 shares of the health services provider’s stock, valued at approximately $632,000.

Other large investors have also made changes to their positions in the company. Assetmark Inc. grew its holdings in Cigna Group by 10.0% during the first quarter. Assetmark Inc. now owns 65,662 shares of the health services provider’s stock valued at $17,515,000 after purchasing an additional 5,963 shares during the period. Mystic Asset Management Inc. purchased a new position in shares of Cigna Group during the 2nd quarter valued at about $2,808,000. KBC Group NV lifted its position in shares of Cigna Group by 6.4% during the 2nd quarter. KBC Group NV now owns 380,034 shares of the health services provider’s stock valued at $104,768,000 after buying an additional 22,978 shares in the last quarter. Sanctuary Advisors LLC bought a new position in shares of Cigna Group during the 2nd quarter valued at approximately $11,043,000. Finally, HighTower Advisors LLC increased its holdings in Cigna Group by 402.7% in the 2nd quarter. HighTower Advisors LLC now owns 354,398 shares of the health services provider’s stock worth $97,701,000 after acquiring an additional 283,897 shares in the last quarter. 86.99% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other news, CAO Jamie G. Kates sold 899 shares of the stock in a transaction that occurred on Friday, June 12th. The stock was sold at an average price of $298.61, for a total transaction of $268,450.39. Following the completion of the transaction, the chief accounting officer directly owned 2,368 shares in the company, valued at approximately $707,108.48. This represents a 27.52% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Nicole S. Jones sold 19,436 shares of the firm’s stock in a transaction on Tuesday, August 4th. The shares were sold at an average price of $276.27, for a total transaction of $5,369,583.72. Following the completion of the transaction, the insider directly owned 27,256 shares of the company’s stock, valued at approximately $7,530,015.12. This trade represents a 41.63% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders have sold 23,012 shares of company stock valued at $6,386,550. 0.60% of the stock is owned by corporate insiders.

Analyst Ratings Changes

A number of research firms have commented on CI. Deutsche Bank Aktiengesellschaft cut shares of Cigna Group from a “buy” rating to a “hold” rating and decreased their target price for the stock from $303.00 to $302.00 in a research note on Wednesday, May 20th. Robert W. Baird set a $362.00 price objective on shares of Cigna Group in a research note on Friday, July 31st. Wells Fargo & Company raised their price objective on shares of Cigna Group from $305.00 to $307.00 and gave the company an “equal weight” rating in a research report on Friday, July 31st. Sanford C. Bernstein lifted their target price on shares of Cigna Group from $371.00 to $381.00 and gave the company an “outperform” rating in a research note on Thursday, July 9th. Finally, Mizuho upped their target price on shares of Cigna Group from $330.00 to $340.00 and gave the stock an “outperform” rating in a report on Monday, June 8th. Fifteen research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $339.45.

Check Out Our Latest Stock Report on Cigna Group

Cigna Group Stock Performance

CI opened at $282.47 on Thursday. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.76 and a current ratio of 0.76. The stock has a market capitalization of $74.64 billion, a price-to-earnings ratio of 11.69, a PEG ratio of 0.97 and a beta of 0.31. The company has a fifty day moving average of $283.45 and a 200 day moving average of $281.10. Cigna Group has a fifty-two week low of $239.51 and a fifty-two week high of $315.47.

Cigna Group (NYSE:CIGet Free Report) last announced its quarterly earnings results on Thursday, July 30th. The health services provider reported $7.78 EPS for the quarter, topping the consensus estimate of $7.60 by $0.18. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The business had revenue of $70.04 billion for the quarter, compared to analysts’ expectations of $70.14 billion. During the same quarter in the previous year, the company earned $7.20 EPS. The business’s quarterly revenue was up 6.7% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.450- EPS. As a group, sell-side analysts forecast that Cigna Group will post 30.51 earnings per share for the current fiscal year.

Cigna Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, September 23rd. Investors of record on Tuesday, September 8th will be paid a dividend of $1.56 per share. The ex-dividend date of this dividend is Tuesday, September 8th. This represents a $6.24 dividend on an annualized basis and a yield of 2.2%. Cigna Group’s dividend payout ratio is presently 25.82%.

Cigna Group Profile

(Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Read More

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.